These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27084146)

  • 1. [Statins according to individual risk].
    Füessl HS; Stiefelhagen P
    MMW Fortschr Med; 2016 Mar; 158(6):35. PubMed ID: 27084146
    [No Abstract]   [Full Text] [Related]  

  • 2. How low is too low: Statin induced hemolysis.
    Pacheco JM; Yilmaz M; Rice L
    Am J Hematol; 2016 Feb; 91(2):267. PubMed ID: 26147873
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fasciculations, cramps, and statins].
    de Entrambasaguas M; Ponz A; Sánchez-Monzó P; Peñaranda N
    Rev Neurol; 2015 Apr; 60(8):380-1. PubMed ID: 25857862
    [No Abstract]   [Full Text] [Related]  

  • 4. To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis.
    Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
    Atherosclerosis; 2015 Aug; 241(2):450-4. PubMed ID: 26074319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Elevation of pancreatic enzymes and facial edema. DRESS syndrome].
    Téllez Villajos L; Rodríguez de Santiago E; Aicart Ramos M; Cuño Roldán JL; Moreira Vicente V; Albillos Martínez A
    Gastroenterol Hepatol; 2015 Jan; 38(1):16-8. PubMed ID: 24939646
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of more intensive lowering of LDL cholesterol.
    Giral P; Moulin P; Rosenbaum D
    Lancet; 2011 Feb; 377(9767):715; author reply 715-6. PubMed ID: 21353895
    [No Abstract]   [Full Text] [Related]  

  • 7. What Is the Appropriate Duration of High-Dose Atorvastatin Therapy Post-Acute Coronary Syndrome?
    Goriacko P; Andersen M; Fazylov R; Plakogiannis R
    J Pharm Pract; 2015 Dec; 28(6):555-60. PubMed ID: 25107416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["No infarct without elevated LDL cholesterol"!].
    Greten H
    MMW Fortschr Med; 2008 Nov; 150(48):119. PubMed ID: 19125517
    [No Abstract]   [Full Text] [Related]  

  • 9. [LDL cholesterol--why lower and lower?].
    Müller-Wieland D; Kotzka J
    MMW Fortschr Med; 2007 May; 149(22):28-30. PubMed ID: 18069223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology: Statins and persistent ulceration.
    Smith DJ; Dillon M; Russell J; Kanatas A
    Br Dent J; 2016 Feb; 220(4):156. PubMed ID: 26917292
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention in coronary heart disease. Can a CSE inhibitor arrest calcium deposits?].
    MMW Fortschr Med; 2001 Apr; 143(14):44. PubMed ID: 11340911
    [No Abstract]   [Full Text] [Related]  

  • 12. Statins and primary prevention: is all the evidence in?
    Rashid S; Francis GA
    Can J Cardiol; 2008 Apr; 24(4):301-3. PubMed ID: 18401471
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
    Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
    Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Following the ASCOT Study. A statin for every hypertensive patient?].
    MMW Fortschr Med; 2003 Apr; 145(16):8. PubMed ID: 14606391
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the effects of two low-density lipoprotein cholesterol goals for secondary prevention after acute myocardial infarction in real-world practice: ≥ 50% reduction from baseline versus <70 mg/dL.
    Cho KH; Jeong MH; Park KW; Kim HS; Lee SR; Chae JK; Hong YJ; Kim JH; Ahn Y; Cho JG; Park JC;
    Int J Cardiol; 2015; 187():478-85. PubMed ID: 25846658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.
    Wanner C; Krane V; März W; Olschewski M; Mann JF; Ruf G; Ritz E;
    N Engl J Med; 2005 Jul; 353(3):238-48. PubMed ID: 16034009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug insight: Statin use in the elderly.
    Raffel OC; White HD
    Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):318-28. PubMed ID: 16729010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL cholesterol goals and cardiovascular risk during statin treatment: the IDEAL study.
    Olsson AG; Lindahl C; Holme I; Fayyad R; Faergeman O; Kastelein JJ; Tikkanen MJ; Larsen ML; Pedersen TR;
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):262-9. PubMed ID: 21450674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein levels and outcomes after statin therapy.
    Ridker PM; Cannon CP; Morrow D; Rifai N; Rose LM; McCabe CH; Pfeffer MA; Braunwald E;
    N Engl J Med; 2005 Jan; 352(1):20-8. PubMed ID: 15635109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipid therapy in daily routine].
    Sonntag F; Schaefer JR; Gitt AK; Weizel A; Jannowitz C; Karmann B; Pittrow D; Bestehorn K
    Dtsch Med Wochenschr; 2012 Oct; 137(40):2047-52. PubMed ID: 23023622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.